- Other backers include Canvas Ventures, American Family Ventures, HC9 Ventures, Valor Capital Group, and Manchester Story
- The funding puts XP Health’s total tally at more than $55 million
- Based in Alexandria, Virginia, QED Investors targets financial services companies
XP Health, a San Carlos, California-based vision care platform, has secured $33.2 million in Series B funding.
QED Investors led the round. Other backers included Canvas Ventures, American Family Ventures, HC9 Ventures, Valor Capital Group, and Manchester Story.
The funding puts XP Health’s total tally at more than $55 million.
“Vision care is an indispensable provision for employee wellbeing, and we are excited to partner with XP Health on building a category leader,” said Victoria Zuo of QED Investors in a statement. “Employees are tired of overpaying for out of pocket costs for vision care. With XP Health, they can now dramatically decrease that expense while enjoying a far superior user experience and product.”
The capital infusion will be used by XP Health to invest in R&D to expand its product offering as well as increase its focus on generative AI products. Also, XP Health will deploy the funding to continue expanding its sales and marketing efforts.
Based in Alexandria, Virginia, QED Investors targets financial services companies. The VC firm was founded by Nigel Morris and Frank Rotman in 2007.
- Other backers include Canvas Ventures, American Family Ventures, HC9 Ventures, Valor Capital Group, and Manchester Story
- The funding puts XP Health’s total tally at more than $55 million
- Based in Alexandria, Virginia, QED Investors targets financial services companies
XP Health, a San Carlos, California-based vision care platform, has secured $33.2 million in Series B funding.
QED Investors led the round. Other backers included Canvas Ventures, American Family Ventures, HC9 Ventures, Valor Capital Group, and Manchester Story.
The funding puts XP Health’s total tally at more than $55 million.
“Vision care is an indispensable provision for employee wellbeing, and we are excited to partner with XP Health on building a category leader,” said Victoria Zuo of QED Investors in a statement. “Employees are tired of overpaying for out of pocket costs for vision care. With XP Health, they can now dramatically decrease that expense while enjoying a far superior user experience and product.”
The capital infusion will be used by XP Health to invest in R&D to expand its product offering as well as increase its focus on generative AI products. Also, XP Health will deploy the funding to continue expanding its sales and marketing efforts.
Based in Alexandria, Virginia, QED Investors targets financial services companies. The VC firm was founded by Nigel Morris and Frank Rotman in 2007.
